Susanne Antonie Schaffert
Director/Board Member bij INCYTE CORPORATION
Vermogen: 14 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Susanne Antonie Schaffert
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 | |
22
| Public Company | Pharmaceuticals: Major | 22 |
20
| Public Company | Biotechnology | 20 |
| Subsidiary | Medical Specialties | 18 | |
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany.
14
| Subsidiary | Pharmaceuticals: Major | 14 |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.
13
| Subsidiary | Miscellaneous | 13 |
CIBA Vision GmbH (Germany)
 CIBA Vision GmbH (Germany) Electronic ComponentsElectronic Technology Part of Alcon AG, CIBA Vision GmbH is a private company based in Grosswallstadt, Germany. CIBA Vision GmbH manufactures and markets contact lenses. The German company was founded in 1983. The CEO is Norbert Dörr.
12
| Subsidiary | Electronic Components | 12 |
| Private Company | Biotechnology | 12 | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Artbio, Inc.
 Artbio, Inc. Hospital/Nursing ManagementHealth Services Artbio, Inc. is a company that is focused on redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building an ecosystem that maximizes their potential. Artbio is based in Cambridge, MA and has subsidiaries in Norway. The company puts the patient at the core of everything they do. The company was founded in 2021 by Emanuele Ostuni, Roy Hartvig Larsen, and Øyvind Sverre Bruland. Emanuele Ostuni has been the CEO since 2021.
2
| Holding Company | Hospital/Nursing Management | 2 |
Vetter Pharma International GmbH
 Vetter Pharma International GmbH Medical DistributorsDistribution Services Part of Vetter Pharma-Fertigung Verwaltungs GmbH, Vetter Pharma International GmbH is a pharmaceutical service provider that offers comprehensive fill-and-finish services from clinical development to commercialization and beyond. The private company is based in Ravensburg, Germany. The German company uses robust, well-controlled testing procedures to verify the quality of every product they release. Vetter is a family-owned company that provides expert manufacturing guidance for injectable drug products. The company has an exclusive collection of in-depth videos that customers can explore. Recently, they responded to increasing market demand by implementing additional equipment for aseptic production and expanding storage capacities at the clinical site. The company was founded in 2009, and the CEO is Peter Sölkner.
1
| Subsidiary | Medical Distributors | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Susanne Antonie Schaffert via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| CELGENE | Biotechnology | Director of Finance/CFO Compliance Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Corporate Officer/Principal Director/Board Member | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Executive Officer | |
| PROGENICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member | |
| MERCK KGAA | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO Chief Executive Officer Director/Board Member Director/Board Member Chairman Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member | |
| NESTLÉ S.A. | Food: Major Diversified | Treasurer Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Founder Director/Board Member | |
| EON SE | Electric Utilities | Director/Board Member Chairman Corporate Secretary | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| ALCON INC. | Medical Specialties | Director of Finance/CFO Director/Board Member | |
| SANOFI | Miscellaneous Commercial Services | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| RADIUS HEALTH, INC. | Biotechnology | Founder Director of Finance/CFO | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Chief Executive Officer Consultant / Advisor Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Director/Board Member Doctorate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| Georgetown University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer President Corporate Officer/Principal Corporate Officer/Principal | |
| University of Copenhagen | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
| ESCP Europe Campus Paris | College/University | Graduate Degree Masters Business Admin | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member | |
Bundesverband der Deutschen Industrie e.V.
 Bundesverband der Deutschen Industrie e.V. Miscellaneous Commercial ServicesCommercial Services Bundesverband der Deutschen Industrie e.V. provides information on the German industry, economy, and economic policies. The private company is based in Berlin, Germany. The German company organizes events that bring together business, politics, science, and civil society for discussions, whether virtually, in-person, or hybrid. The company was founded by Gerhard Schempp. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member Director/Board Member | |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Director of Investments | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| AXCA HEALPAR | Biotechnology | Founder Director/Board Member Chairman | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Chairman Chief Administrative Officer | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Chairman | |
| Merck Life Science KGaA | Director/Board Member Chairman Director/Board Member | ||
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| MODERNA, INC. | Biotechnology | Director/Board Member Founder General Counsel | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 31 |
| Duitsland | 6 |
| Denemarken | 6 |
| Zwitserland | 5 |
| Frankrijk | 4 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Finance | 4 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 541 |
| Corporate Officer/Principal | 239 |
| Independent Dir/Board Member | 140 |
| Chairman | 106 |
| Chief Executive Officer | 80 |
Sterkste connecties
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| Kapil Dhingra | 39 |
| Karl-Ludwig Kley | 32 |
| Michael Rosenblatt | 31 |
| David Epstein | 28 |
| Francois Nader | 28 |
| Abhijeet Lele | 27 |
| Felix R. Ehrat | 27 |
| Thomas Dyrberg | 24 |
| Pablo Cagnoni | 24 |
| Jérôme Contamine | 23 |
| Belén Garijo López | 22 |
| Lars Rebien Sørensen | 22 |
| Jean-Jacques Bienaimé | 21 |
| Søren Møller | 21 |
- Beurs
- Insiders
- Susanne Antonie Schaffert
- Bedrijfsconnecties
